Raymond James Financial Services Advisors’s Chemours CC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $509K | Buy |
25,071
+118
| +0.5% | +$2.41K | ﹤0.01% | 2602 |
|
|
2024
Q2 | $563K | Sell |
24,953
-4,315
| -15% | -$113K | ﹤0.01% | 2445 |
|
|
2024
Q1 | $769K | Sell |
29,268
-163
| -0.6% | -$4.64K | ﹤0.01% | 2223 |
|
|
2023
Q4 | $928K | Buy |
29,431
+3,206
| +12% | +$87K | ﹤0.01% | 2024 |
|
|
2023
Q3 | $736K | Sell |
26,225
-1,518
| -5% | -$52.1K | ﹤0.01% | 2088 |
|
|
2023
Q2 | $1.02M | Sell |
27,743
-6,492
| -19% | -$198K | ﹤0.01% | 1920 |
|
|
2023
Q1 | $1.02M | Sell |
34,235
-54,323
| -61% | -$1.79M | ﹤0.01% | 1883 |
|
|
2022
Q4 | $2.71M | Sell |
88,558
-13,256
| -13% | -$398K | 0.01% | 1277 |
|
|
2022
Q3 | $2.51M | Sell |
101,814
-546
| -0.5% | -$18K | 0.01% | 1299 |
|
|
2022
Q2 | $3.28M | Buy |
102,360
+8,509
| +9% | +$313K | 0.01% | 1154 |
|
|
2022
Q1 | $2.95M | Buy |
93,851
+47,119
| +101% | +$1.47M | 0.01% | 1277 |
|
|
2021
Q4 | $1.57M | Buy |
46,732
+2,724
| +6% | +$84.9K | ﹤0.01% | 1693 |
|
|
2021
Q3 | $1.28M | Buy |
44,008
+5,903
| +15% | +$191K | ﹤0.01% | 1779 |
|
|
2021
Q2 | $1.33M | Buy |
38,105
+1,789
| +5% | +$59.2K | ﹤0.01% | 1750 |
|
|
2021
Q1 | $1.01M | Buy |
36,316
+4,635
| +15% | +$123K | ﹤0.01% | 1858 |
|
|
2020
Q4 | $785K | Sell |
31,681
-402
| -1% | -$9.56K | ﹤0.01% | 1860 |
|
|
2020
Q3 | $671K | Buy |
32,083
+8,345
| +35% | +$161K | ﹤0.01% | 1795 |
|
|
2020
Q2 | $364K | Sell |
23,738
-21,623
| -48% | -$273K | ﹤0.01% | 2124 |
|
|
2020
Q1 | $402K | Buy |
45,361
+24,834
| +121% | +$358K | ﹤0.01% | 1672 |
|
|
2019
Q4 | $371K | Buy |
20,527
+5,519
| +37% | +$91.7K | ﹤0.01% | 2179 |
|
|
2019
Q3 | $224K | Sell |
15,008
-398
| -3% | -$6.47K | ﹤0.01% | 2418 |
|
|
2019
Q2 | $370K | Sell |
15,406
-1,078
| -7% | -$31.8K | ﹤0.01% | 2128 |
|
|
2019
Q1 | $613K | Sell |
16,484
-559
| -3% | -$20.3K | ﹤0.01% | 1753 |
|
|
2018
Q4 | $481K | Buy |
17,043
+906
| +6% | +$28.7K | ﹤0.01% | 1698 |
|
|
2018
Q3 | $636K | Buy |
16,137
+32
| +0.2% | +$1.4K | ﹤0.01% | 1743 |
|
|
2018
Q2 | $715K | Sell |
16,105
-716
| -4% | -$35.6K | ﹤0.01% | 1633 |
|
|
2018
Q1 | $819K | Sell |
16,821
-5,693
| -25% | -$285K | ﹤0.01% | 1434 |
|
|
2017
Q4 | $1.13M | Buy |
22,514
+1,352
| +6% | +$70.8K | 0.01% | 1224 |
|
|
2017
Q3 | $1.07M | Buy |
21,162
+6,722
| +47% | +$317K | 0.01% | 1259 |
|
|
2017
Q2 | $547K | Sell |
14,440
-779
| -5% | -$30.7K | ﹤0.01% | 1628 |
|
|
2017
Q1 | $586K | Sell |
15,219
-4,420
| -23% | -$133K | ﹤0.01% | 1484 |
|
|
2016
Q4 | $434K | Sell |
19,639
-1,015
| -5% | -$20.8K | ﹤0.01% | 1603 |
|
|
2016
Q3 | $330K | Sell |
20,654
-16,204
| -44% | -$185K | ﹤0.01% | 1726 |
|
|
2016
Q2 | $304K | Sell |
36,858
-8,035
| -18% | -$71.6K | ﹤0.01% | 1715 |
|
|
2016
Q1 | $314K | Sell |
44,893
-1,695
| -4% | -$8.52K | ﹤0.01% | 1524 |
|
|
2015
Q4 | $250K | Buy |
+46,588
| New | +$298K | ﹤0.01% | 1467 |
|
Other funds holding CC
KCM
VNIM
Raymond James Financial Services Advisors's CC Position: Q3 2024 in Review
Raymond James Financial Services Advisors increased its Chemours (CC) stake by 0.47% in Q3 2024, buying an estimated $2.41K and bringing the position to 25,071 shares worth $509K. The position accounts for ﹤0.01% of the portfolio, ranked #2602.
Raymond James Financial Services Advisors first reported a position in CC in Q4 2015 and has held it in 36 quarters since. The position peaked at $3.28M in Q2 2022. 421 funds tracked by Wall St. Rank hold CC as of Q3 2024.
- Raymond James Financial Services Advisors held 25,071 shares of Chemours worth $509K as of Q3 2024.
- Raymond James Financial Services Advisors bought 118 Chemours shares in Q3 2024, an estimated $2.41K.
- Chemours made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2602 holding.
- Raymond James Financial Services Advisors first reported a position in Chemours in Q4 2015 and has held it in 36 quarters since.
- Raymond James Financial Services Advisors's Chemours position peaked at $3.28M in Q2 2022.
- 421 funds tracked by Wall St. Rank held Chemours as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.